Ariumi Project Laboratory, Center for AIDS Research - International Research Center for Medical Sciences, Kumamoto University Kumamoto, Japan.
Front Genet. 2014 Dec 5;5:423. doi: 10.3389/fgene.2014.00423. eCollection 2014.
The DEAD-box RNA helicase DDX3 is a multifunctional protein involved in all aspects of RNA metabolism, including transcription, splicing, mRNA nuclear export, translation, RNA decay and ribosome biogenesis. In addition, DDX3 is also implicated in cell cycle regulation, apoptosis, Wnt-β-catenin signaling, tumorigenesis, and viral infection. Notably, recent studies suggest that DDX3 is a component of anti-viral innate immune signaling pathways. Indeed, DDX3 contributes to enhance the induction of anti-viral mediators, interferon (IFN) regulatory factor 3 and type I IFN. However, DDX3 seems to be an important target for several viruses, such as human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), hepatitis B virus (HBV), and poxvirus. DDX3 interacts with HIV-1 Rev or HCV Core protein and modulates its function. At least, DDX3 is required for both HIV-1 and HCV replication. Therefore, DDX3 could be a novel therapeutic target for the development of drug against HIV-1 and HCV.
DEAD-box RNA 解旋酶 DDX3 是一种多功能蛋白,参与 RNA 代谢的各个方面,包括转录、剪接、mRNA 核输出、翻译、RNA 降解和核糖体生物发生。此外,DDX3 还与细胞周期调控、细胞凋亡、Wnt-β-catenin 信号通路、肿瘤发生和病毒感染有关。值得注意的是,最近的研究表明 DDX3 是抗病毒先天免疫信号通路的一个组成部分。事实上,DDX3 有助于增强抗病毒介质干扰素(IFN)调节因子 3 和 I 型 IFN 的诱导。然而,DDX3 似乎是几种病毒的重要靶标,如人类免疫缺陷病毒 1 型(HIV-1)、丙型肝炎病毒(HCV)、乙型肝炎病毒(HBV)和痘病毒。DDX3 与 HIV-1 Rev 或 HCV Core 蛋白相互作用并调节其功能。至少,DDX3 是 HIV-1 和 HCV 复制所必需的。因此,DDX3 可能成为开发抗 HIV-1 和 HCV 药物的新的治疗靶标。